Marketable Securities	6 Months Ended
Jun. 30, 2023
Marketable Securities
Marketable Securities	Note 4 – Marketable Securities Our marketable securities consist of equity securities classified as available-for-sale (“AFS”). AFS securities are carried at fair value on the condensed consolidated balance sheets. Realized and unrealized gains and losses are reported in earnings within “other income (expense), net”. The specific identification method is used to determine realized gains and losses on AFS securities. During the three months ended June 30, 2023 and 2022, we purchased $0 and $3.8 million of marketable securities, respectively, and we sold $0 of marketable equity securities in each period. During the six months ended June 30, 2023 and 2022, we purchased $0 and $6.0 million of marketable securities, respectively, and we sold $0 of marketable equity securities in each period. During the three months ended June 30, 2023 and 2022, gross realized and unrealized gains were $0 and $318,000, respectively, and gross realized and unrealized losses were $0 in each period. During the six months ended June 30, 2023 and 2022, gross realized and unrealized gains were $0 and $225,000, respectively, and gross realized and unrealized losses were $0 in each period. As of June 30, 2023, we had no marketable equity securities.

Marketable Securities

6 Months Ended

Jun. 30, 2023

Note 4 – Marketable Securities

Our marketable securities consist of equity securities classified as available-for-sale (“AFS”). AFS securities are carried at fair value on the condensed consolidated balance sheets. Realized and unrealized gains and losses are reported in earnings within “other income (expense), net”. The specific identification method is used to determine realized gains and losses on AFS securities. During the three months ended June 30, 2023 and 2022, we purchased $0 and $3.8 million of marketable securities, respectively, and we sold $0 of marketable equity securities in each period. During the six months ended June 30, 2023 and 2022, we purchased $0 and $6.0 million of marketable securities, respectively, and we sold $0 of marketable equity securities in each period. During the three months ended June 30, 2023 and 2022, gross realized and unrealized gains were $0 and $318,000, respectively, and gross realized and unrealized losses were $0 in each period. During the six months ended June 30, 2023 and 2022, gross realized and unrealized gains were $0 and $225,000, respectively, and gross realized and unrealized losses were $0 in each period. As of June 30, 2023, we had no marketable equity securities.